• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开角型青光眼的两阶段氩激光小梁成形术

Two-stage argon laser trabeculoplasty in open-angle glaucoma.

作者信息

Klein H Z, Shields M B, Ernest J T

出版信息

Am J Ophthalmol. 1985 Apr 15;99(4):392-5. doi: 10.1016/0002-9394(85)90003-0.

DOI:10.1016/0002-9394(85)90003-0
PMID:3985077
Abstract

Forty-five adults with primary open-angle glaucoma received argon laser trabeculoplasty in two stages (180 degrees in each session) separated by one month. The indication for argon laser trabeculoplasty in each case was uncontrolled glaucoma consisting of progressive optic disk cupping and visual field loss despite maximally tolerable medication. A P value of .01 by Student's two-tailed paired t-test was used for statistical significance in the analysis of the intraocular pressure data. In most cases, the greatest reduction in intraocular pressure followed stage 1. Some patients received no additional benefit from stage 2; in other cases, the second stage was not only beneficial but provided most of the reduction in pressure. The pretreatment intraocular pressure level influenced the response to laser therapy. Patients with the highest pretreatment intraocular pressures received the most benefit. Both stages were complicated by a transient postoperative increase of 5 mm Hg or more in 12 patients (approximately 19%).

摘要

45例原发性开角型青光眼成人患者接受了氩激光小梁成形术,分两个阶段进行(每次180度),间隔1个月。每个病例进行氩激光小梁成形术的指征是尽管使用了最大耐受剂量的药物,但青光眼仍未得到控制,表现为进行性视盘凹陷和视野缺损。在分析眼压数据时,采用学生双尾配对t检验,P值为0.01作为统计学显著性标准。在大多数情况下,眼压最大降幅出现在第1阶段后。一些患者在第2阶段未获得额外益处;在其他情况下,第2阶段不仅有益,而且提供了大部分的眼压降低。治疗前眼压水平影响对激光治疗的反应。治疗前眼压最高的患者受益最大。两个阶段均有12例患者(约19%)术后眼压短暂升高5 mmHg或更多,出现了并发症。

相似文献

1
Two-stage argon laser trabeculoplasty in open-angle glaucoma.开角型青光眼的两阶段氩激光小梁成形术
Am J Ophthalmol. 1985 Apr 15;99(4):392-5. doi: 10.1016/0002-9394(85)90003-0.
2
[Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].[氩激光治疗100例开角型青光眼(小梁成形术、小梁退缩术)的结果]
J Fr Ophtalmol. 1983;6(8-9):661-70.
3
Some factors affecting the intraocular pressure reduction after argon laser trabeculoplasty in open-angle glaucoma.一些影响开角型青光眼氩激光小梁成形术后眼压降低的因素。
Acta Ophthalmol (Copenh). 1984 Oct;62(5):696-704. doi: 10.1111/j.1755-3768.1984.tb05796.x.
4
Argon laser trabeculoplasty in younger patients with primary open-angle glaucoma.
Am J Ophthalmol. 1984 Mar;97(3):292-5. doi: 10.1016/0002-9394(84)90625-1.
5
Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma.
Arch Ophthalmol. 1985 Oct;103(10):1482-4. doi: 10.1001/archopht.1985.01050100058018.
6
Intraocular pressure and visual field defects after argon laser trabeculoplasty in chronic open-angle glaucoma.慢性开角型青光眼氩激光小梁成形术后的眼压及视野缺损
Ophthalmology. 1987 May;94(5):553-7. doi: 10.1016/s0161-6420(87)33412-8.
7
Argon laser trabeculoplasty following failed trabeculectomy.小梁切除术后失败的氩激光小梁成形术
Ophthalmic Surg. 1984 Mar;15(3):195-8.
8
Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.选择性激光小梁成形术与氩激光小梁成形术治疗开角型青光眼的长期疗效比较
Ophthalmology. 2004 Oct;111(10):1853-9. doi: 10.1016/j.ophtha.2004.04.030.
9
Argon laser trabeculoplasty in the presurgical glaucoma patient.术前青光眼患者的氩激光小梁成形术
Ophthalmology. 1982 Mar;89(3):187-97. doi: 10.1016/s0161-6420(82)34807-1.
10
Comparative study of argon laser trabeculoplasty in primary open-angle and pseudoexfoliation glaucoma.氩激光小梁成形术治疗原发性开角型青光眼和假性剥脱性青光眼的对比研究
Ophthalmologica. 1989;198(2):57-63. doi: 10.1159/000309960.

引用本文的文献

1
Argon laser trabeculoplasty controls one third of patients with progressive, uncontrolled open-angle glaucoma for five years.
Trans Am Ophthalmol Soc. 1991;89:47-56; discussion 56-8.